Advanced in Small Cell Lung Cancer (SCLC)

Dirk J. Jager

Heidelberg, BW, DE 
Advanced in Small Cell Lung Cancer (SCLC)
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Dirk Jager practices in Heidelberg, Germany. Mr. Jager is rated as an Advanced expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Measles, Parainfluenza, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

His clinical research consists of co-authoring 357 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Small Cell Lung Cancer (SCLC).

Gender
Male

Locations

Heidelberg, BW, Germany
Other Locations
Mainz, RP, Germany
Salem, BW, Germany
Ulm, BW, Germany
Applied Tumor Immunity, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A First-in-human Dose Escalation and Dose Finding Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)
A First-in-human Dose Escalation and Dose Finding Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)
Enrollment Status: Completed
Publish Date: November 21, 2024
Intervention Type: Drug
Study Phase: Phase 1

357 Total Publications

Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial).
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial).
Journal: BMJ open
Published: September 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jager's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile